PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Cellix Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Cellix is Successful Grant Recipient of FP7 Marie Curie Industry Academia Grant - The European Commission recently awarded an FP7 Marie Curie Industry Academia Partnership and Pathways (IAPP) grant, termed Target-Melanoma, totalling €1,736,483 to Prof. William Gallagher’s group at University College Dublin
Cellix is Successful Grant Recipient of FP7 Marie Curie Industry Academia Grant

 

NewswireToday - /newswire/ - Dublin, Ireland, 2009/11/18 - The European Commission recently awarded an FP7 Marie Curie Industry Academia Partnership and Pathways (IAPP) grant, termed Target-Melanoma, totalling €1,736,483 to Prof. William Gallagher’s group at University College Dublin.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The grant, which will run from 2009-2013, will be distributed between the consortium members comprising academic institutions and industrial organisations including the UCD Conway Institute, University College Dublin (Co-ordinator, Ireland), Cellix Ltd. (Ireland), Institut d'Investigacio Biomedica de Bellvitge (Spain), University of Maastricht (The Netherlands), University Hospitals and Katholieke Universiteit Leuven (Belgium), Swedish Human Proteome Resource and Uppsala University (Sweden), OncoMethylome Sciences (Belgium), SlidePath (Ireland) and OncoMark Ltd. (Ireland).

“These funds will go toward ensuring we continue to dissect the molecular basis of melanoma progression, with a view towards translating this information for patient benefit.” commented Prof. William Gallagher, co-ordinator of Target-Melanoma. “In this wide-ranging project, we have assembled an integrated collection of complementary research groups across Europe from both academic and industry sectors, which work closely together via intersectoral exchanges to mediate key new insights into this poorly understood disease”.

Cellix is a particularly useful partner in this project in that it will work closely with UCD to generate a novel flow culture model for extravasation, which will be a key tool to facilitate bridging between in vitro and in vivo studies”.

The main goals of the Target-Melanoma project are as follows;
• Identification of methylated genes involved in melanoma progression (benign nevi to metastases) and methylation profiling in clinical samples.
• Validation and functional interrogation of melanoma progression-associated genes via tissue microarray (TMA) technologies and in vitro analysis.

“This is the second grant Cellix have received under the Marie Curie scheme following the successful completion of the “ASTHMA” project which ran from April 2006 to April 2009 and resulted in the development of Cellix’s VenaEC biochip” says Vivienne Williams, CEO, Cellix.

The Target-Melanoma project involves significant interplay between industrial, basic science and clinical spheres. By further developing and sharing combined sets of skills, as well as applying the latest developments in TMA, DNA methylation and in vitro techniques, this project aims to fast-track the validation of putative melanoma targets identified from transcriptomic screens.

The Marie Curie IAPP funding is available for universities, research organisations, and businesses in the EU or Associated States to provide early-stage and experienced researchers with structured scientific or technological opportunities of between three months to three years. The main focus of the IAPP program is to mediate cross-sectoral exchanges between academic and industrial partners.

About Cellix Ltd
Cellix Ltd (cellixltd.com) is a privately held instrumentation and cell-based assay company developing technologies that accurately mimic in vivo human blood vessels under physiological flow for cell-based screening in drug discovery. The Company is headquartered in Dublin, Ireland, and maintains offices in New York City.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Cellix Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Cellix is Successful Grant Recipient of FP7 Marie Curie Industry Academia Grant

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Rachel Ashe - CellixLtd.com 
+353 1 896 27 99 r.ashe[.]cellixltd.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Cellix Ltd securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Cellix Ltd / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Frost & Sullivan Recognizes Ventec Life Systems for New Product Innovation - Game-changing, Modular Respiratory System, VOCSN
BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
GE Healthcare Advances the Delivery of Cell Therapies with New Thawing Technology
Ansell Limited Announces the Closing of the Sale of its Sexual Wellness Business
PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for its Proprietary DETOUR System for Percutaneous Bypass
Curaçao EMS Uses ZOLL Autopulse to Save Tourist in Sudden Cardiac Arrest
ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017
MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
Datalogic Announces New Healthcare Memor X3 HC Mobile Computer
Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow Ltd

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)